| Verified against primary record | |
| Universal Health Insurance Law | Law No. 2 of 2018, with coverage to become universal in six phases over 15 years[2] |
|---|---|
| Phase one as legislated | Port Said, Suez, Ismailia, South Sinai and North Sinai[2] |
| Phase one as implemented | North Sinai removed on security grounds; Luxor and Aswan moved up from phase two[2] |
| Accreditation body | The General Authority for Healthcare Accreditation and Regulation accredits hospitals, clinics and laboratories[2] |
| Private clinic participation | Judged unlikely to enrol during the first two to three years[2] |
| Medicines | About 90 per cent locally manufactured[2] |
| Medical tourism in the WHO country strategy | Not mentioned in the 2024 to 2028 strategy[1] |
| Independently reported | |
| Regional pattern | Visa restrictions were said to have pushed many Middle Eastern patients toward Southeast Asia[3] |
| Bands apply only to the rows beneath them. The insurance and accreditation detail comes from a World Bank project document dated December 2019, so the phase sequence it records is the position at that date and may since have changed. No count of foreign patients treated in Egypt, no revenue figure and no outbound patient figure was located, and none has been estimated. No typical cost range is given because no official Egyptian source publishes prices paid by foreign patients. | |
Medical tourism in Egypt is absent from the official record, which is instead occupied by something larger: a fifteen-year programme to build universal health insurance from scratch, with a new national accreditation authority attached to it. Neither the WHO country cooperation strategy for Egypt nor the World Bank project documentation supporting the insurance reform mentions foreign patients at all.
The insurance reform
Egypt’s Universal Health Insurance Law is Law No. 2 of 2018, under which coverage is to become universal across the country in six phases over fifteen years. A World Bank environmental and social review summary for the project supporting the system, dated 13 December 2019, records that the law placed Port Said, Suez, Ismailia, South Sinai and North Sinai in phase one, and that the government then removed North Sinai citing security and moved Luxor and Aswan up from phase two citing infrastructure readiness.[2]
The document gives Egypt’s population as about 100 million, with about 5.6 million people in the six phase-one governorates including roughly 2 million poor people. Poverty rates in those governorates, on 2018 figures from the national statistics agency, ranged from 6.7 per cent in Port Said and 20 per cent in Suez through 32 per cent in Ismailia and 46 per cent in Aswan to 51 per cent in South Sinai and 55 per cent in Luxor. Total project cost was 511.28 million United States dollars, with the Ministry of Finance as borrower and implementing agency.[2]
Starting universal coverage in governorates where between a third and more than half the population is poor is a deliberate sequencing choice, and it establishes what Egyptian health policy is for. The programme is aimed at the uninsured Egyptian poor, not at building capacity that could be sold to visitors.
Accreditation, and why it matters here
Under the reform, the Universal Health Insurance Agency handles revenue collection and contracting while the General Authority for Healthcare Accreditation and Regulation accredits providers, including hospitals, clinics and laboratories. The World Bank document records an expectation that the accreditation criteria will yield good-quality services, and notes that its environment and facility safety standard was to be gap-analysed against World Bank Group environmental health and safety guidelines before appraisal.[2]
A national accreditation authority with statutory standing is the infrastructure a destination country needs if foreign patients are ever to have an objective quality signal to rely on, and Egypt now has one where several countries covered on this site do not. Whether it functions as such is a separate question that the record consulted does not answer.
The same document is candid about limits. Private clinics were judged unlikely to enrol during the first two to three years, few facilities might qualify for accreditation in the poorer governorates, and remote and rural areas face a shortage of trained workers. About 90 per cent of medicines are locally manufactured, and the net effect of the reform on private doctors, pharmacists, pharmaceutical companies and private insurers was described as uncertain.[2]
What the WHO strategy sets out
The country cooperation strategy for WHO and Egypt covering 2024 to 2028, published on 5 November 2025 and running to 56 pages, sets five strategic priorities: enhancing health and well-being throughout the life course; strengthening the health system towards universal health coverage including access to and expanded coverage of quality essential health services; enhancing prevention, preparedness and response for health security; strengthening health equity, governance and leadership; and supporting digital health innovation for better health outcomes. These align with WHO’s Fourteenth General Programme of Work.[1]
Medical tourism and foreign patients are not mentioned.[1]
Egypt is frequently promoted commercially as a destination for dental treatment, cosmetic surgery, ophthalmology and hepatitis C care, the last on the strength of its national elimination programme. No official Egyptian figure quantifying treatment of foreign patients was located for this article, and none has been estimated.
Regional context
A 2015 briefing by an economist at the United States International Trade Commission, published as the author’s own views rather than those of the Commission, recorded that visa restrictions had pushed many Middle Eastern patients toward Southeast Asia. It is included as the only sourced statement on regional patient movement located for this entry, and it names no countries of treatment or origin.[3]
Limits of the evidence
Neither source consulted gives national health spending as a share of gross domestic product, an out-of-pocket share, hospital bed counts or physician and nurse densities for Egypt, so none is stated here. The insurance phase sequence is as recorded in December 2019 and may since have changed. The full 56-page WHO strategy was not retrieved; statements about it are limited to its publication entry. No Egyptian Ministry of Health statistical series on foreign patients, and no accreditation register listing accredited facilities, was located.
See also
- Medical tourism and universal health coverage, the programme occupying Egyptian health policy
- Clinical outcomes in medical tourism, which national accreditation is meant to signal
- Medical tourism and health equity, in governorates where half the population is poor
- Medical tourism in Jordan, the regional destination with industry figures but no official ones
- Medical tourism and local access to care, the tension a coverage rollout makes explicit
References
- WHO Regional Office for the Eastern Mediterranean. Country cooperation strategy for WHO and Egypt, 2024-2028. Published 5 November 2025, 56 pages, ISBN 9789292746926. Verified against primary record: the publication entry was opened and the period covered, the publisher, the publication date, the page count, the stated basis for the next phase of cooperation and coordination with the United Nations Country Team, the five strategic priorities of health and well-being throughout the life course, health system strengthening towards universal health coverage, prevention preparedness and response for health security, health equity governance and leadership, and digital health innovation, the alignment with WHO’s Fourteenth General Programme of Work, and the absence of any reference to medical tourism or foreign patients were read directly. Only the publication entry was read; the full document was not retrieved. Retrieved 23 October 2026.
- World Bank. Concept Environmental and Social Review Summary: Supporting Egypt’s Universal Health Insurance System. Report No. ESRSC00981, project P172426, 13 December 2019. Verified against primary record: the document was opened and the identification of the Universal Health Insurance Law as Law No. 2 of 2018, the plan for universal coverage in six phases over fifteen years with no calendar dates given, the legislated phase one of Port Said, Suez, Ismailia, South Sinai and North Sinai, the removal of North Sinai citing security and the advancement of Luxor and Aswan from phase two citing infrastructure readiness, the national population of about 100 million, the 5.6 million people in the six phase-one governorates including roughly 2 million poor people, the governorate poverty rates on 2018 national statistics agency figures, the total project cost of USD 511.28 million, the Ministry of Finance as borrower and implementing agency, the roles of the Universal Health Insurance Agency in revenue collection and contracting and of the General Authority for Healthcare Accreditation and Regulation in accrediting hospitals, clinics and laboratories, the expectation that accreditation criteria would yield good-quality services, the planned gap analysis of the accreditation body’s environment and facility safety standard against World Bank Group guidelines, the judgement that private clinics were unlikely to enrol in the first two to three years, the risk that few facilities would qualify for accreditation in poorer governorates, the shortage of trained workers in remote and rural areas, the figure of about 90 per cent of medicines being locally manufactured, the uncertainty of net effects on private stakeholders, the absence of national figures for health spending, out-of-pocket share, beds, physicians, nurses or facility counts, and the absence of any reference to medical tourism or foreign patients were read directly. Retrieved 23 October 2026.
- Chambers, A. Trends in U.S. Health Travel Services Trade. Office of Industries, United States International Trade Commission, Executive Briefing on Trade, August 2015. Independently reported: the briefing was opened and the statement that visa restrictions had pushed many Middle Eastern patients towards Southeast Asia was read. The briefing states that the views expressed are the author’s and not those of the Commission, and it is placed in this band for that reason. Retrieved 23 October 2026.
Sourcing note: no national health system indicators are given for Egypt in this entry, because neither source consulted contains them and importing them from elsewhere would mean citing a document that was not read. Egypt’s commercial promotion as a destination is described as promotion and is not quantified. The insurance phase sequence is dated to December 2019 wherever it appears, since a rollout of this kind changes. Nothing has been estimated.